Biogen Inc. buy UBS Group AG
Start price
22.04.26
/
50%
€162.56
Target price
22.04.27
€191.59
Performance (%)
8.27%
Price
27.07.26
€176.00
Summary
This prediction is currently active. With a performance of 8.27%, the BUY prediction by UBS_Group_AG for Biogen Inc. is trending in the right direction. This prediction currently runs until 22.04.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | 0.525% | 0.525% |
| iShares Core DAX® | 2.992% | 3.220% |
| iShares Nasdaq 100 | -1.584% | -3.172% |
| iShares Nikkei 225® | -2.254% | -9.924% |
| iShares S&P 500 | -0.009% | 1.641% |
Comments by UBS_Group_AG for this prediction
In the thread Biogen Inc. diskutieren
Biogen (BIIB) was upgraded by UBS Group AG from "neutral" to "buy". They now have a $225.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat